Ubtech Robotics Waits for U1 Cash as Index Nod Fails to Lift Sentiment

Thousands of pre-orders for Ubtech's U1 humanoid robot face a July 16 conversion deadline; only paid sales count as revenue. Stock down 33% YTD, conversion rate critical for growth.

The clock has run out on thousands of would-be buyers of Ubtech Robotics’ UWORLD U1 humanoid robot. By the close of business on July 16, 2026, customers who placed refundable deposits of around 3,000 renminbi had to make full payment or walk away. The tally of more than 13,361 pre-orders that Ubtech touted at the end of June will now be put to the test — only those that convert into paid invoices count toward revenue.

The conversion deadline arrives at a pivotal moment for the Chinese robotics group. Shares have lost roughly a third of their value since the start of the year, and the stock recently touched a 52-week low of 8.91 EUR before clawing back to 9.97 EUR, a 3.82% gain on the day. The Relative Strength Index of 43.3 suggests neutral momentum, while annualized 30-day volatility of 85.71% underscores the market’s frayed nerves. Despite the near-term price weakness, Ubtech was formally added to the HKEX Tech 100 index on 13 July, a recognition of its growing footprint in the technology sector.

The U1 series — priced between 119,800 renminbi for the Lite version and up to 990,000 renminbi for the premium Ultra model — is Ubtech’s boldest bet yet on the mass market. The company sold only 1,079 full-size humanoid robots in 2025, so the U1’s success is critical to its next growth phase. At the Shenzhen launch event on June 30, Ubtech claimed it had already logged more than 13,361 orders, though those were effectively non-binding reservations. Now the hard numbers will emerge.

Behind the public enthusiasm, Ubtech’s financials tell a cautionary tale. Revenue rose 53.3% to 2.01 billion renminbi in 2025, and gross margin improved from 28.7% to 37.7%. But net losses, though reduced from 12.34 billion renminbi in 2023, still stood at 7.03 billion renminbi last year. Operating cash flow remains negative, and trade receivables of 18.42 billion renminbi — more than 40% of which are over a year old — weigh on the balance sheet. At a price-to-sales ratio of 18.2, the stock commands a premium that many analysts view as hard to justify without a rapid ramp in commercial deliveries.

Competition is heating up from multiple directions. Domestic rival Unitree Technology recently completed its IPO on Shanghai’s STAR Market at a valuation of roughly 420 billion renminbi, having already shipped more than 5,500 humanoid units in 2025 — over five times Ubtech’s tally. Adding to the pressure, Tesla is rumored to be preparing small-series production of its Optimus Gen-3, raising the stakes for the entire sector. Ubtech is fighting back through a partnership with the Boshi Group to place robots in luxury car showrooms, an attempt to broaden distribution beyond industrial channels.

The next milestone comes in August 2026, when Ubtech is expected to report quarterly results that will show how many U1 reservations hardened into actual sales. If conversion rates are high, the company may begin to justify its lofty valuation. If not, the gap between market hype and operating reality will only widen — and the stock’s recent bounce from 8.91 EUR could prove short-lived. For now, the Chinese humanoid robot maker is living on a promise that thousands of buyers are ready to follow through.